A peerless review? Automating methodological and statistical review
Peer review is the primary mechanism for ensuring the integrity of the published literature; however, it is a human system with all of a human's fallibilities.… Read more »
Daniel Shanahan
Associate Publisher at BioMed Central
Daniel has an MA in Natural Sciences and MSc in Experimental and Theoretical Physics from University of Cambridge. A staunch advocate for transparency and reproducibility in research, he joined BioMed Central in 2013 as Associate Publisher for Medical Evidence.
Latest posts by Daniel Shanahan (see all)
- A peerless review? Automating methodological and statistical review - 23rd May 2016
- Clinical trial data and articles linked for the first time - 18th May 2016
- Research Integrity and Peer Review: the Editors’ wish list - 3rd May 2016
Clinical trial data and articles linked for the first time
After years of hard work, linked clinical trials are here! It's now possible to link all published articles related to a clinical trial through the CrossMark… Read more »
Research Integrity and Peer Review: the Editors’ wish list
How can the journal Research Integrity and Peer Review advance research and publication? Daniel Shanahan asked the Editors-in-Chief for their thoughts on what… Read more »
Transparency is the future, but do ‘pharma’ have their heads in the sand?
Transparency has been one of the defining trends in biomedical research over the last decade. However, as the recent case of Richmond Pharmacology Ltd vs the UK… Read more »
The WHO have issued the challenge, now it is up to us
In a statement issued last week, the World Health Organization has added its voice to the growing demands for clinical trial transparency. But what will change,… Read more »
Evidence based medicine: a movement in crisis or just one with a long way to go?
Is evidence-based medicine (EBM) actually working? Trisha Greenhalgh asked this in an editorial in the BMJ last year and this was the focus of the lively… Read more »
Research Involvement and Engagement: Partnership with patients in a new publication
“No matter how complicated the research, or how brilliant the researcher, patients and the public always offer unique, invaluable insights. Their advice when… Read more »
Where’s the evidence for how we run clinical trials?
No one ever said that doing a clinical trial was easy. Indeed it often feels like a Sisyphean task, when faced with obdurate funding committees, or centres that… Read more »
The CONSORT Statement in 2014: from Miró to Pollock?
With the advent of the AllTrials initiative, the EU Clinical Trials Regulation and the recent Tamiflu debacle, randomized controlled trials (RCTs) have received… Read more »
A brave new world – ‘research with’ not ‘research on’ patients
‘On the 20th of May 1747, I took twelve patients in the scurvy, on board the Salisbury at sea. Their cases were as similar as I could have them.’ James Lind… Read more »